Harry Björkbacka
TitleCited byYear
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
H Björkbacka, VV Kunjathoor, KJ Moore, S Koehn, CM Ordija, MA Lee, ...
Nature medicine 10 (4), 416, 2004
6842004
The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades
H Bjorkbacka, KA Fitzgerald, F Huet, X Li, JA Gregory, MA Lee, CM Ordija, ...
Physiological Genomics 19 (3), 319-330, 2004
3052004
Gene expression in autumn leaves
R Bhalerao, J Keskitalo, F Sterky, R Erlandsson, H Björkbacka, SJ Birve, ...
Plant Physiology 131 (2), 430-442, 2003
3042003
Elevated CD14++CD16 Monocytes Predict Cardiovascular Events
KE Berg, I Ljungcrantz, L Andersson, C Bryngelsson, B Hedblad, ...
Circulation: Cardiovascular Genetics 5 (1), 122-131, 2012
1692012
Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function
BS Franklin, P Parroche, MA Ataíde, F Lauw, C Ropert, RB de Oliveira, ...
Proceedings of the National Academy of Sciences 106 (14), 5789-5794, 2009
1532009
Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation
I Gonçalves, A Edsfeldt, NY Ko, H Grufman, K Berg, H Björkbacka, ...
Arteriosclerosis, thrombosis, and vascular biology 32 (6), 1505-1512, 2012
1362012
Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide
U Diczfalusy, KE Olofsson, AM Carlsson, M Gong, DT Golenbock, ...
Journal of lipid research 50 (11), 2258-2264, 2009
1332009
Multiple roles of Toll-like receptor signaling in atherosclerosis
H Björkbacka
Current opinion in lipidology 17 (5), 527-533, 2006
1172006
Low levels of circulating CD4+ FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke
M Wigren, H Björkbacka, L Andersson, I Ljungcrantz, GN Fredrikson, ...
Arteriosclerosis, thrombosis, and vascular biology 32 (8), 2000-2004, 2012
1052012
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine
M Wigren, D Kolbus, P Dunér, I Ljungcrantz, I Söderberg, H Björkbacka, ...
Journal of internal medicine 269 (5), 546-556, 2011
912011
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B‐100 transgenic mice without inducing an increase in peptide‐specific antibodies
GN Fredrikson, H Björkbacka, I Söderberg, I Ljungcrantz, J Nilsson
Journal of internal medicine 264 (6), 563-570, 2008
852008
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
S Elsøe, J Ahnström, C Christoffersen, AN Hoofnagle, P Plomgaard, ...
Atherosclerosis 221 (1), 91-97, 2012
822012
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe-/-mice
D Kolbus, OH Ramos, KE Berg, J Persson, M Wigren, H Björkbacka, ...
BMC immunology 11 (1), 58, 2010
742010
Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study
M Persson, G Engström, H Björkbacka, B Hedblad
Atherosclerosis 220 (2), 502-505, 2012
712012
T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke
D Engelbertsen, L Andersson, I Ljungcrantz, M Wigren, B Hedblad, ...
Arteriosclerosis, thrombosis, and vascular biology 33 (3), 637-644, 2013
672013
Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells
M Wigren, D Bengtsson, P Dunér, K Olofsson, H Björkbacka, ...
Circulation Research 104 (12), e62-e70, 2009
652009
Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals
OS Cotoi, P Dunér, N Ko, B Hedblad, J Nilsson, H Björkbacka, A Schiopu
Arteriosclerosis, thrombosis, and vascular biology 34 (1), 202-210, 2014
602014
Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis–a review of the experimental evidence
H Björkbacka, GN Fredrikson, J Nilsson
Atherosclerosis 227 (1), 9-17, 2013
602013
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages
KE Olofsson, L Andersson, J Nilsson, H Björkbacka
Biochemical and biophysical research communications 370 (2), 348-352, 2008
602008
Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque
A Edsfeldt, M Nitulescu, H Grufman, C Grönberg, A Persson, M Nilsson, ...
Stroke 43 (12), 3305-3312, 2012
572012
The system can't perform the operation now. Try again later.
Articles 1–20